NEW YORK, Oct. 4, 2017 /PRNewswire/ -- A new global healthcare report finds that an astonishing 62.5 percent of U.S.
"The GHWR represents the patient's voice and offers an unfettered, patient-centric view of the true impact of almost 200 health conditions," said Michael Fronstin, General Manager of Health Outcomes, Forecasting and Epidemiology, Kantar Health. "While the 2017 report indicates that progress has been made in patient care, there's more work to be done to improve the lives of people suffering with various conditions, as across geographies the rates of diagnosis and treatment vary widely and demonstrate much room for improvement."
Key Global FindingsPublished yearly since 2008, Kantar Health's GHWR provides incomparable patient insights on the most pressing health issues of today for the United States, Japan, the EU5 (France, Germany, Italy, Spain and U.K.), and key Emerging Markets Brazil, China and Russia.
Key U.S. FindingsWhile U.S. healthcare reform remains in limbo, the manner in which pre-existing conditions will ultimately be dealt with is a key concern for many Americans. The GHWR finds that 152 million Americans (62.5 percent of U.S. adults) have now been diagnosed with a condition that could be termed "preexisting" for future health services. Furthermore, to combat the sometimes high-costs of treatment, 41 percent of U.S. adults diagnosed with a pre-existing condition report using a cost savings strategy – such as cutting tablets in half, taking less medicine than prescribed, buying fewer pills or buying them less often than directed – to offset the costs of prescription medicines. The report also confirms that the United States has the largest obese population at 31.5 percent of adults, which is certainly a key factor for the United States having the highest rates of metabolic diseases such as high cholesterol, hypertension, obesity, thyroid condition, and type 1 and type 2 diabetes. Finally, the United States has the highest level of strong opioid use, which has led to significant and growing addiction issues, including injecting opioids.
The EU5, Japan and the Emerging MarketsThe GHWR finds that the EU5 is currently facing a variety of challenges given socialized medicine and its impact on the healthcare environment. As access and reimbursement remain a consistent focus for Health Technology Assessments (HTAs), payers and governments across Europe, the unintended consequence is an incremental burden placed on manufacturers and patients. While there are many similarities between Japan and the EU5, the largest difference is that Japan is transitioning to a full scale HTA and requiring effectiveness and economic information. Additionally, like the EU5, Japan is experiencing an aging population and an increase in national healthcare costs as a percentage of GDP. Finally, The Emerging Markets have their own challenges related to access and reimbursement. Quantifying the magnitude of disease within major cities versus rural areas remains a challenge, and access to quality healthcare is limited in various parts of Emerging Market countries.
"The GHWR provides unique value in understanding the magnitude of diseases and the impact on people living with them, both within and across countries," said Fronstin. "Undoubtedly there are areas to improve across the 10 countries evaluated, as levels of diagnosis remain low in some countries, untreated populations are high in others, and societal stigmas are preventing many sufferers from seeking medical care. However, these factors present opportunities to drive awareness in these undiagnosed and/or untreated populations – such as encouraging patients who are experiencing conditions to seek treatment and educating physicians about the unintended humanistic and economic consequences of not diagnosing or treating appropriately."
For a full copy of Kantar Health's GHWR, please visit www.kantarhealth.com.
* Conditions include: AIDS/HIV, Alcohol or drug abuse with recent treatment, Alzheimer's/dementia, Arthritis, Cancer, Congestive heart failure, Coronary artery/heart disease/bypass surgery, Crohn's disease, Diabetes, Epilepsy, Hemophilia, Hepatitis, Kidney disease/renal failure, Lupus, Mental disorders (including Anxiety, Bipolar Disorder, Depression, Obsessive Compulsive Disorder, Schizophrenia), Multiple sclerosis, Muscular dystrophy, Organ transplant, Parkinson's disease, Sleep apnea, Stroke, Acid Reflux, Acne, Asthma, C-Section, Heart burn, High cholesterol, Hysterectomy, Migraines, Narcolepsy, Pacemaker, Ulcers.
About Kantar HealthKantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.
Contact Gary Gatyas +1 215 820 6621 [email protected]
View original content:http://www.prnewswire.com/news-releases/preexisting-conditions-rise-in-us-patient-care-remains-inconsistent-globally-new-health-report-finds-300530307.html
SOURCE Kantar Health
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All